Role of TNF‐α in virus‐induced airway hyperresponsiveness and neuronal M2muscarinic receptor dysfunction
Open Access
- 1 April 2011
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 164 (2b) , 444-452
Abstract
BACKGROUND AND PURPOSEInfections with respiratory viruses induce exacerbations of asthma, increase acetylcholine release and potentiate vagally mediated bronchoconstriction by blocking inhibitory M2muscarinic receptors on parasympathetic neurons. Here we test whether virus‐induced M2receptor dysfunction and airway hyperresponsiveness are tumour necrosis factor‐alpha (TNF‐α) dependent.EXPERIMENTAL APPROACHGuinea pigs were pretreated with etanercept or phosphate‐buffered saline 24 h before intranasal infection with parainfluenza. Four days later, pulmonary inflation pressure, heart rate and blood pressure were measured. M2receptor function was assessed by the potentiation by gallamine (an M2receptor antagonist) of bronchoconstriction caused by electrical stimulation of the vagus nerves and measured as increased pulmonary inflation pressure. Human airway epithelial cells were infected with influenza and TNF‐α concentration in supernatant was measured before supernatant was applied to human neuroblastoma cells. M2receptor expression in these neuroblastoma cells was measured by qRT‐PCR.KEY RESULTSInfluenza‐infected animals were hyperresponsive to vagal stimulation but not to intravenous ACh. Gallamine did not potentiate vagally induced bronchoconstriction in virus‐infected animals, indicating M2receptor dysfunction. Etanercept prevented virus‐induced airway hyperresponsiveness and M2receptor dysfunction, without changing lung viral titres. Etanercept caused a non‐significant decrease in total cells, macrophages and neutrophils in bronchoalveolar lavage. Influenza infection significantly increased TNF‐α release from isolated epithelial cells, sufficient to decrease M2receptors in neuroblastoma cells. This ability of supernatants from infected epithelial cells to inhibit M2receptor expression was blocked by etanercept.CONCLUSIONS AND IMPLICATIONSTNF‐α is a key mediator of virus‐induced M2muscarinic receptor dysfunction and airway hyperresponsiveness.Keywords
This publication has 51 references indexed in Scilit:
- Guide to Receptors and Channels (GRAC), 4th editionBritish Journal of Pharmacology, 2009
- Etanercept prevents airway hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen‐challenged guinea pigsBritish Journal of Pharmacology, 2008
- Constitutive IKK2 activation in acinar cells is sufficient to induce pancreatitis in vivoJournal of Clinical Investigation, 2007
- Intravitreal Toxicity of High-Dose EtanerceptJournal of Ocular Pharmacology and Therapeutics, 2007
- Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammationJournal of Clinical Investigation, 2006
- Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in childrenThorax, 2006
- Anti-TNF-α and Th1 cytokine-directed therapies for the treatment of asthmaCurrent Opinion in Allergy and Clinical Immunology, 2006
- Tumour necrosis factor (TNF ) as a novel therapeutic target in symptomatic corticosteroid dependent asthmaThorax, 2005
- Organophosphorus Insecticides Induce Airway Hyperreactivity by Decreasing Neuronal M2 Muscarinic Receptor Function Independent of Acetylcholinesterase InhibitionToxicological Sciences, 2004
- Tumour necrosis factor‐α: The role of this multifunctional cytokine in asthmaImmunology & Cell Biology, 2001